Alset shareholders adopted FY2025 financial statements at AGM

Advent Technologies Holdings
ALSERES PHARMACEUTICALS INC

Advent Technologies Holdings

AEI

0.00

ALSERES PHARMACEUTICALS INC

ALSE

0.00

  • Alset International held its annual general meeting on April 30, 2026, adopting audited financial statements for year ended Dec. 31, 2025.
  • Shareholders backed reappointment of Foo Kon Tan LLP as auditor, with board authorized to set auditor remuneration.
  • Mandate granted for directors to allot and issue shares, including via instruments convertible into shares, within stated limits.
  • Authority approved to offer and grant share options under 2024 Alset International Limited Share Option Scheme, with related share issuance permitted within scheme limits.
  • Authority approved to offer and grant share awards under 2024 Alset International Limited Performance Share Plan, with related share issuance permitted within plan limits.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alset International Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 23W2NJLKE9DR8IEX) on May 04, 2026, and is solely responsible for the information contained therein.